
Pharming Group Investor Relations Material
Latest events

Study Update
Pharming Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Pharming Group N.V.
Access all reports
Pharming Group N.V. is a global biopharmaceutical company based in Leiden, the Netherlands. The company specializes in the development and commercialization of protein replacement therapies and precision medicines, particularly for rare diseases. Pharming's key product is RUCONEST, a plasma-free recombinant human C1 esterase inhibitor used for treating acute hereditary angioedema (HAE). The company also has several other products in various stages of development, including treatments for Pompe and Fabry diseases and other rare disorders. The company is headquartered in Leiden, the Netherlands, and its shares are listed on both the Amsterdam Euronext and Nasdaq.
Key slides for Pharming Group N.V.


Study Update
Pharming Group N.V.


AGM 2025
Pharming Group N.V.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
PHARM
Country
🇳🇱 Netherlands